Antibody Clonality:
Polyclonal
Application:
Western Blot (WB)
Storage:
Store antibody at -20˚C for up to one year.
No additional charges, what you see is what you pay! *
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available!
Contact us to find what you can save.
This product comes from:
United States.
Typical lead time:
14-21 working days.
Contact us for more accurate information.
- Further Information
- Documents
- Show All
Further Information
CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, RAF, CDSIGN
Western Blot: 1:500~1:1000
Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. Thought to mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments. The receptor returns to the cell membrane surface and the pathogen-derived antigens are presented to resting T-cells via MHC class II proteins to initiate the adaptive immune response. Probably recognizes in a calcium-dependent manner high mannose N-linked oligosaccharides in a variety of pathogen antigens, including HIV-1 gp120, HIV-2 gp120, SIV gp120, ebolavirus glycoproteins, cytomegalovirus gB, HCV E2, dengue virus gE, Leishmania pifanoi LPG, Lewis-x antigen in Helicobacter pylori LPS, mannose in Klebsiella pneumonae LPS, di-mannose and tri-mannose in Mycobacterium tuberculosis ManLAM and Lewis-x antigen in Schistosoma mansoni SEA. On DCs it is a high affinity receptor for ICAM2 and ICAM3 by binding to mannose-like carbohydrates. May act as a DC rolling receptor that mediates transendothelial migration of DC presursors from blood to tissues by binding endothelial ICAM2. Seems to regulate DC-induced T-cell proliferation by binding to ICAM3 on T-cells in the immunological synapse formed between DC and T-cells.
- Geijtenbeek T. B. H., Kwon D. S., Torensma R., van Vliet S. J., van Duijnhoven G. C. F., Middel J., Cell 100:587-597 (2000) Geijtenbeek T. B. H., Krooshoop D. J., Bleijs D. A., van Vliet S. J., van Duijnhoven G. C. F., Grabovsky Nat. Immunol. 1:353-357 (2000) Engering A., Geijtenbeek T. B. H., van Vliet S. J., van Kooyk Y. J. Immunol. 168:2118-2126 (2002)
Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
1 mg/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
CD209 (DC-SIGN) antibody was raised against a peptide sequence around aa.389~393 ( E-Q-F-L-S ) derived from Human CD209 (DC-SIGN).
30835
CD209 molecule
CD209
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
46 kDa
NP_066978.1
10863957
Antibodies were purified by affinity-chromatography using epitope-specific peptide.
Other
This antibody detects endogenous level of total CD209 (DC-SIGN) protein.
Q9NNX6